Urology Resident Rutgers New Jersey Medical School
Introduction: The da Vinci Single-Port robotic system (SP) was approved by the Food and Drug Administration for use in urologic procedures in 2018 and since, its implementation has become widespread. This case series highlights the feasibility and surgical technique when performing sacrocolpopexy using the SP system.
Methods: We reviewed cases of SP robotic sacrocolpopexy performed by a single surgeon at a single institution.
Results: N=4 patients underwent SP robotic sacrocolpopexy. Mean operative time was 86 minutes. Mean estimated blood loss was 55 milliliters. All patients were discharged home on post-operative day one and no complications were noted.
Conclusions: SP sacrocolpopexy is a feasible alternative to multiport sacrcolpopexy. With fewer incisions, single port surgery potentially enables less post-operative pain and improved cosmesis. Single port surgery has an associated learning curve and limitations that warrant further evaluation. We observed that the SP system is better suited for small to medium size uteruses given the limited grip and movement strength of the SP instruments. Further comparison to multiport sacrcolpopexy is ongoing at our institution.
.jpg)
.jpg)
